- Sunesis Pharmaceuticals (SNSS) enters a repurchase program of up to $15.5M shares with Aspire Capital Fund.
- Under the agreement, Aspire Capital has made an initial investment by purchasing $500K worth of common shares at $2.19/share.
- Aspire Capital commits to purchasing up to an additional $15M of common shares at the request of Sunesis during a 24-month period.
- Sunesis Pharmaceuticals shares are up 1.9% aftermarket to $2.15.
Sunesis +1.9% on $15.5M repurchase agreement
Recommended For You
More Trending News
About VIRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
VIRX | - | - |
Viracta Therapeutics, Inc. |